Tech Company Financing Transactions
BaroSense Funding Round
BaroSense closed a $10 million Series B financing round on 1/31/2005. Investors included Delphi Ventures, Frazier Healthcare Partners and INVESCO Private Capital.
Transaction Overview
Company Name
Announced On
1/31/2005
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Proceeds Purpose
BaroSense is developing an obesity solution that yields substantial weight loss without the risks of surgery and side effects of pharmaceuticals.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
250 Chesapeake Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Not Recorded
Overview
BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for theobese.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alan Levy
Chief Executive Officer
Daniel Balbierz
VP - Human Resources
Desiree Pascual
VP - Operations
Paul Bell
VP - R & D
David Cole
VP - Regulatory Affairs
Sheila Stevens
Browse more venture capital transactions:
Prev: 1/26/2005: Paymetric venture capital transaction
Next: 1/31/2005: Xaffire venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs